Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
31.37
-0.46 (-1.45%)
Feb 24, 2026, 3:00 PM CST
Market Cap12.98B +81.4%
Revenue (ttm)850.99M +29.7%
Net Income7.28M
EPS0.02
Shares Out407.81M
PE Ratio1,782.58
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,636,434
Average Volume10,082,356
Open31.93
Previous Close31.83
Day's Range31.02 - 32.15
52-Week Range14.86 - 44.99
Beta0.78
RSI49.22
Earnings DateMar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 973
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements